Cargando…

Oral administration of the K(ATP )channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis

BACKGROUND: Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disorder of the central nervous system (CNS) and is the leading cause of nontraumatic disability among young adults. Activated microglial cells are important effectors of demyelination and neurodegeneration, by secreting c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virgili, Noemí, Espinosa-Parrilla, Juan F, Mancera, Pilar, Pastén-Zamorano, Andrea, Gimeno-Bayon, Javier, Rodríguez, Manuel J, Mahy, Nicole, Pugliese, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215935/ https://www.ncbi.nlm.nih.gov/pubmed/22047130 http://dx.doi.org/10.1186/1742-2094-8-149

Ejemplares similares

K(ATP) Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation
por: Virgili, Noemí, et al.
Publicado: (2013)

Correction: K(ATP) Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation
por: Virgili, Noemí, et al.
Publicado: (2013)

Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice
por: Mancera, Pilar, et al.
Publicado: (2017)

Molecular determinants of ATP-sensitive potassium channel MgATPase activity: diabetes risk variants and diazoxide sensitivity
por: Fatehi, Mohammad, et al.
Publicado: (2015)

ATP-sensitive potassium (K(ATP)) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway
por: Roy Chowdhury, Uttio, et al.
Publicado: (2017)

Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
por: Villoslada, Pablo, et al.
Publicado: (2015)

Regulation of K(ATP) Channel Activity by Diazoxide and MgADP : Distinct Functions of the Two Nucleotide Binding Folds of the Sulfonylurea Receptor
por: Shyng, S.-L., et al.
Publicado: (1997)

Isosteviol Sensitizes sarcK(ATP) Channels towards Pinacidil and Potentiates Mitochondrial Uncoupling of Diazoxide in Guinea Pig Ventricular Myocytes
por: Fan, Zhuo, et al.
Publicado: (2016)

ATP—Sensitive Potassium Channel Opener Diazoxide Reduces Myocardial Stunning in a Porcine Regional With Subsequent Global Ischemia Model
por: Velez, Ana K., et al.
Publicado: (2022)

Diazoxide Attenuates Postresuscitation Brain Injury in a Rat Model of Asphyxial Cardiac Arrest by Opening Mitochondrial ATP-Sensitive Potassium Channels
por: Wu, Haidong, et al.
Publicado: (2016)

The mitochondrial K-ATP channel opener diazoxide upregulates STIM1 and Orai1 via ROS and the MAPK pathway in adult rat cardiomyocytes
por: Gavali, Joice T., et al.
Publicado: (2020)

Effects of diazoxide in experimental acute necrotizing pancreatitis
por: de Oliveira Andrade, Roberta, et al.
Publicado: (2017)

Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions
por: Friciu, Mihaela, et al.
Publicado: (2016)

The danger of diazoxide in the neonatal intensive care unit
por: Desai, Jay, et al.
Publicado: (2021)

Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension
por: Newman-Lindsay, Shoshana, et al.
Publicado: (2022)

Adenosine Triphosphate-Sensitive Potassium Channel Kir Subunits Implicated in Cardioprotection by Diazoxide
por: Henn, Matthew C, et al.
Publicado: (2015)

Diazoxide affects mitochondrial bioenergetics by the opening of mKATP channel on submicromolar scale
por: Akopova, Olga, et al.
Publicado: (2020)

Diazoxide Promotes Oligodendrocyte Precursor Cell Proliferation and Myelination
por: Fogal, Birgit, et al.
Publicado: (2010)

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

Diazoxide preconditioning antagonizes cytotoxicity induced by epileptic seizures★
por: Fu, Qingxi, et al.
Publicado: (2013)

Prevalence and safety of diazoxide in the neonatal intensive care unit
por: Gray, Keyaria D, et al.
Publicado: (2018)

Diazoxide for Lowering Insulin Levels in Breast Cancer Patients
por: Fink, Michael K., et al.
Publicado: (2017)

Successful medical management of insulinoma with diazoxide for 27 years
por: Warren, Annabelle M, et al.
Publicado: (2020)

Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1
por: Sotiridou, Ellada, et al.
Publicado: (2021)

Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism
por: Boskabadi, Seyyed Javad, et al.
Publicado: (2023)

Pulmonary hypertension associated with diazoxide: the SUR1 paradox
por: Montani, David, et al.
Publicado: (2023)

Anticonvulsant Effect of Diazoxide against Dichlorvos-Induced Seizures in Mice
por: Jazayeri, Amin, et al.
Publicado: (2013)

Diazoxide Maintains Human Myocyte Volume Homeostasis During Stress
por: Maffit, Sara K., et al.
Publicado: (2012)

A case of insulinoma effectively treated with low‐dose diazoxide
por: Yasuda, Atsushi, et al.
Publicado: (2020)

Necrotizing enterocolitis following diazoxide therapy for persistent neonatal hypoglycemia
por: Theodorou, Christina M., et al.
Publicado: (2019)

Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy
por: Sullivan, Rachel T., et al.
Publicado: (2021)

Targeting Microglial K(ATP) Channels to Treat Neurodegenerative Diseases: A Mitochondrial Issue
por: Rodríguez, Manuel J., et al.
Publicado: (2013)

Pharmacological Preconditioning Using Diazoxide Regulates Store-Operated Ca(2 +) Channels in Adult Rat Cardiomyocytes
por: Sampieri, Raúl, et al.
Publicado: (2020)

Cardiac Subsarcolemmal and Interfibrillar Mitochondria Display Distinct Responsiveness to Protection by Diazoxide
por: Holmuhamedov, Ekhson L., et al.
Publicado: (2012)

Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
por: Hussain, Suhaimi, et al.
Publicado: (2015)

Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia
por: Loke, Kah-Yin, et al.
Publicado: (2016)

Pulmonary hypertension occurring with diazoxide use in a preterm infant with hypoglycemia
por: Kylat, Ranjit I
Publicado: (2019)

Diazoxide for the Treatment of Hypoglycemia Resulting From Dumping Syndrome in a Child
por: Mejia-Otero, Juan D, et al.
Publicado: (2019)

Efficacy and safety of octreotide treatment for diazoxide‐unresponsive congenital hyperinsulinism in China
por: Cao, Bingyan, et al.
Publicado: (2020)

Hypoglycemia in a Non-diabetic Patient and the Side Effects of Diazoxide Use
por: Brito, Patrícia C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ru5q89d1kucmn0o4u8fvvj5kjg